Carboplatin Injection Market Outlook 2029: Presents Market Insights & Depth Analysis

The global carboplatin injection market is expected to grow at a significant CAGR during the forecast period.  Carboplatin is a chemotherapeutic drug that is offered under various brand names, including Paraplatin. It is used to treat a variety of cancers including ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma. It is administered through a venous injection. The increasing prevalence of cancer is contributing to the growth of the market. For instance, as per Cancer.gov, in the US, head and neck cancers account for roughly 4% of all cancers. Men are more than twice as likely as women affected with these cancers. Cancers of the head and neck are also diagnosed more frequently in those over 50 than in younger people. In 2021, more than 68,000 men and women in the US were diagnosed with head and neck cancers. The majority of people were diagnosed with mouth, throat, or voice box cancer. 

Further, according to Cancer.org, ovarian cancer is the sixth leading cause of cancer mortality in women, killing more women than any other cancer of the female reproductive system. A woman's lifetime risk of developing ovarian cancer is roughly 1 in 78. Her chances of dying from ovarian cancer are roughly 1 in 108 in her lifetime. This cancer primarily affects women in their 40 or 50s. About half of all women diagnosed with ovarian cancer are above the age of 63. White women are more likely to have it than African-American women. However, over the last 20 years, the number of women diagnosed with ovarian cancer has steadily decreased. Carboplatin is utilized alone or in combination with other medications for the treatment of cancer of the ovaries that has spread to other parts of the body, not improved, and worsened after treatment with other radiation or medications therapy. It belongs to a class of medications referred to as platinum-containing compounds. It works by inhibiting or slowing the growth of cancer cells.

To Request a Sample of our Report on Carboplatin Injection Market:  https://www.omrglobal.com/request-sample/carboplatin-injection-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030
Segment Covered
Regions Covered- Globally
Competitive Landscape: Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Sanofi SA, among others. 

Carboplatin Injection Market Report by Segment

By Product Type 

10 ML :50MG
10 ML:100MG

By Application 

Breast Cancer
Ovarian Cancer
SCLC 
Others

A full Report of Carboplatin Injection Market is Available at:  https://www.omrglobal.com/industry-reports/carboplatin-injection-market

Carboplatin Injection Market by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.